Chemotherapy-associated pseudocellulitis: a case series of four patients

Max E Oscherwitz1, Madison Read2, Josh Pelia3

  • 1Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

PubMed

Insights

Chemotherapy-associated pseudocellulitis (CAP) mimics infections, leading to misdiagnosis. This case series highlights four CAP cases to improve identification and avoid unnecessary treatments.

Area of Science:

  • Dermatology
  • Oncology
  • Internal Medicine

Background:

  • Pseudocellulitis is non-necrotizing inflammation of the skin and subcutaneous tissue from noninfectious causes.
  • It can be misdiagnosed as cellulitis, leading to inappropriate workups and antibiotic prescriptions.
  • Chemotherapy-associated pseudocellulitis (CAP) is a specific form that requires accurate identification.

Purpose of the Study:

  • To describe four unique cases of chemotherapy-associated pseudocellulitis (CAP).
  • To discuss methods for identifying CAP and differentiating it from infectious cellulitis.
  • To reduce misdiagnosis and unnecessary treatment in patients receiving chemotherapy.

Main Methods:

  • A case series approach was used.
  • Four cases of chemotherapy-associated pseudocellulitis were identified and described.
  • Clinical presentation, diagnostic challenges, and management strategies were reviewed.

Main Results:

  • The four cases presented with features that mimicked infectious cellulitis.
  • Accurate diagnosis of CAP was achieved through careful clinical evaluation and exclusion of infection.
  • Prompt recognition can prevent unnecessary antibiotic use and further investigations.

Conclusions:

  • Chemotherapy-associated pseudocellulitis is a critical differential diagnosis in patients undergoing cancer treatment.
  • Awareness and specific diagnostic criteria are essential for correct identification.
  • Improved diagnostic accuracy for CAP can optimize patient care and resource utilization.